ESPL1
Basic information
Region (hg38): 12:53268299-53293638
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ESPL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 12 | ||||
missense | 74 | 11 | 92 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 75 | 22 | 9 |
Variants in ESPL1
This is a list of pathogenic ClinVar variants found in the ESPL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-53268793-T-C | ESPL1-related disorder | Likely benign (Aug 07, 2019) | ||
12-53269059-C-T | ESPL1-related disorder | Likely benign (Mar 25, 2019) | ||
12-53269117-C-G | not specified | Uncertain significance (Jan 24, 2024) | ||
12-53269139-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
12-53269170-G-C | not specified | Uncertain significance (May 03, 2023) | ||
12-53269180-C-G | not specified | Uncertain significance (Oct 29, 2021) | ||
12-53269289-C-T | ESPL1-related disorder | Benign (Jun 17, 2019) | ||
12-53269327-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
12-53269343-A-G | not specified | Uncertain significance (Jan 17, 2023) | ||
12-53269376-G-A | not specified | Uncertain significance (May 10, 2022) | ||
12-53269612-C-T | not specified | Uncertain significance (Jul 05, 2022) | ||
12-53269652-G-A | not specified | Likely benign (Apr 05, 2023) | ||
12-53269667-T-G | not specified | Uncertain significance (Sep 06, 2022) | ||
12-53269675-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
12-53269676-C-A | not specified | Uncertain significance (Feb 28, 2023) | ||
12-53269738-C-T | not specified | Likely benign (Mar 16, 2023) | ||
12-53269744-C-A | not specified | Uncertain significance (Mar 27, 2023) | ||
12-53269927-C-G | not specified | Uncertain significance (Oct 04, 2022) | ||
12-53269937-C-T | not specified | Uncertain significance (Oct 24, 2023) | ||
12-53269955-A-C | not specified | Uncertain significance (Feb 01, 2023) | ||
12-53269991-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
12-53270012-T-C | not specified | Likely benign (Oct 26, 2022) | ||
12-53270720-A-C | not specified | Uncertain significance (Nov 09, 2023) | ||
12-53270728-C-T | ESPL1-related disorder | Likely benign (Sep 18, 2019) | ||
12-53270756-G-T | not specified | Uncertain significance (Aug 30, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ESPL1 | protein_coding | protein_coding | ENST00000257934 | 30 | 25345 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 4.19e-10 | 125570 | 0 | 177 | 125747 | 0.000704 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.31 | 755 | 1.17e+3 | 0.645 | 0.0000675 | 13530 |
Missense in Polyphen | 116 | 314.68 | 0.36863 | 3910 | ||
Synonymous | 1.51 | 447 | 489 | 0.913 | 0.0000262 | 4579 |
Loss of Function | 8.38 | 9 | 99.0 | 0.0909 | 0.00000550 | 1061 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00473 | 0.00474 |
Ashkenazi Jewish | 0.000904 | 0.000893 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000772 | 0.000765 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000330 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Caspase-like protease, which plays a central role in the chromosome segregation by cleaving the SCC1/RAD21 subunit of the cohesin complex at the onset of anaphase. During most of the cell cycle, it is inactivated by different mechanisms. {ECO:0000269|PubMed:10411507, ECO:0000269|PubMed:11509732}.;
- Pathway
- Cell cycle - Homo sapiens (human);Oocyte meiosis - Homo sapiens (human);Cell Cycle;Regulation of sister chromatid separation at the metaphase-anaphase transition;DroToll-like;Separation of Sister Chromatids;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.291
- rvis_EVS
- 1.8
- rvis_percentile_EVS
- 96.89
Haploinsufficiency Scores
- pHI
- 0.201
- hipred
- Y
- hipred_score
- 0.691
- ghis
- 0.443
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.494
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Espl1
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; embryo phenotype; liver/biliary system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; neoplasm; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype;
Zebrafish Information Network
- Gene name
- espl1
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- curvature
Gene ontology
- Biological process
- mitotic sister chromatid segregation;meiotic spindle organization;mitotic cytokinesis;proteolysis;apoptotic process;establishment of mitotic spindle localization;homologous chromosome segregation;positive regulation of mitotic metaphase/anaphase transition;negative regulation of sister chromatid cohesion;meiotic chromosome separation
- Cellular component
- nucleus;cytoplasm;centrosome;cytosol;mitotic spindle
- Molecular function
- catalytic activity;cysteine-type endopeptidase activity;protein binding;cysteine-type peptidase activity